AMSTERDAM, Feb. 22, 2023 /PRNewswire/ Freya Pharma Solutions, a late clinical stage company focusing on the development of effective pharmaceutical therapies for women diagnosed with Female
/PRNewswire/ Freya Pharma Solutions, a late clinical stage company focusing on the development of effective pharmaceutical therapies for women diagnosed.
Dr. Irwin Goldstein, Sue Goldstein, Prof. Sheryl Kingsberg, and Dr. Rachel Rubin AMSTERDAM, Feb. 10, 2023 /PRNewswire/ Freya Pharma Solutions, a late clinical stage company focusing
Report on the first meeting - contribution of the SAB to the pivotal phase 3 clinical trial protocol for Lybrido, to be finalized soon hereafter AMSTERDAM, May 25, 2022 /PRNewswire/